Home » Topics » Regulatory

Regulatory
RSS

Another ANDA approval for Gensia

Dec. 8, 1997

SangStat signs ciclosporin agreement with Amgen

Dec. 8, 1997

Oncaspar approved in Canada

Dec. 5, 1997

Gensia Laboratories receives generic approval

Dec. 5, 1997

Intermittent therapy with 5-HT reuptake inhibitor effective for dysphoric PMS

Dec. 3, 1997

Imitrex Nasal Spray now available in U.S.

Dec. 2, 1997

Muse approved in U.K.

Dec. 2, 1997

Recombinant IFN-beta-1a from Ares-Serono reduces relapses, delays progression in MS

Dec. 2, 1997

FDA approves Gensia Laboratories' generic bumetanide injection

Dec. 1, 1997

Teva receives FDA approval for generic etodolac

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...